Shares are likely to trade down as the effect notice triggers immediate pricing of the offerings. Expect significant dilution in the coming days. Monitor for a pricing announcement and potential reverse stock split to maintain Nasdaq listing.
Price Chart
Executive Summary
Aethlon Medical's S-1 registration (File No. 333-296933) became effective on July 6, 2026, allowing the company to proceed with its dilutive best-efforts offering of common stock and warrants. The company is pre-revenue with a going-concern qualification and a ~$2M market cap, making this capital raise critical for survival but highly dilutive for existing shareholders. The offerings, targeting up to ~$12M at $2.00/unit and ~$4M at $0.85/unit, are expected to price soon.
Key Facts
- S-1 registration 333-296933 declared effective by SEC on 2026-07-06
- Company is pre-revenue with a going-concern qualification
- Two concurrent best-efforts offerings: up to 6,000,000 units at $2.00 and up to 4,705,882 units at $0.85 (from prior S-1/A filings)
- Market cap is approximately $2 million, making dilution severe
- Stock trades below Nasdaq's $1.00 minimum bid price, creating delisting risk
Financial Impact
Combined gross proceeds of up to ~$16M (undisclosed final amount) from two best-efforts offerings, representing massive dilution relative to a ~$2M market cap
Risk Factors
- Severe dilution to existing shareholders upon pricing of the offerings
- Nasdaq delisting if bid price remains below $1.00
- Going-concern risk if the capital raise underperforms or operational milestones are missed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002203 |
| Document: 9999999995-26-002203-index.html | 9999999995-26-002203 |
| Document: 9999999995-26-002203.txt | 9999999995-26-002203 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | SC 13G | $5.05 $5.07 | ▲ +0.40% | ▼ −0.06% | $5.24 (+3.76%) |
Oct 1, 2026 24d ago | 8-K | $6.45 $6.05 | ▲ +6.20% | ▲ +7.36% | $5.24 (+18.76%) |
Sep 17, 2026 5w ago | 425 | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.24 (−22.71%) |
Sep 17, 2026 5w ago | 8-K | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.24 (−22.71%) |
Sep 15, 2026 5w ago | 8-K | $1.47 $6.31 | ▲ +329.25% | ▲ +328.43% | $5.24 (+256.46%) |
Sep 4, 2026 7w ago | DEFA14A | $1.81 $1.47 | ▲ +18.78% | ▲ +17.67% | $5.24 (−189.50%) |
Aug 31, 2026 8w ago | 8-K | $2.06 $1.81 | ▼ −12.14% | ▼ −11.99% | $5.24 (+154.37%) |
Aug 13, 2026 10w ago | Press Release | $2.83 $2.73 | ▼ −3.53% | ▼ −2.17% | $5.24 (+85.16%) |
Jul 31, 2026 12w ago | 8-K | $0.6628 $0.6300 | ▲ +4.95% | ▲ +8.46% | $5.24 (−690.59%) |
Jul 7, 2026 15w ago | EFFECT | $0.7297 $0.6850 | ▲ +6.13% | ▲ +6.68% | $5.24 (−618.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers